Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda (MILEAGE4TB)
Using Short Message Service Reminders, Phone Calls and Mobile Money Incentives to Enhance Linkage to Care of Presumptive Tuberculosis Patients in Uganda: a Randomised Controlled Trial
The major challenge in meeting the WHO's End TB Strategy- reducing tuberculosis (TB) deaths by 90% and incidence by 80% is the cascading patient loss-to-follow-up (LTFU) along the continuum of TB care. A systematic review found high levels of pre-treatment LTFU-ranging from 4 to 38%, and was higher in sub-Saharan Africa (18%) compared to Asia (13%). Consequences of pre-diagnosis and pre-treatment LTFU are; untreated TB patients are infectious and can transmit TB to others and not starting TB treatment at all, causes high morbidity and mortality. Therefore, monitoring outcomes of presumptive TB patients is equally important as monitoring treatment outcomes. Short message service (SMS), phone calls and mobile money (MM) incentives have shown promise by improving health outcomes such as uptake of immunization, adherence to TB treatment and antiretroviral therapy (ART). However, there is limited knowledge their effect in increasing linkage to care and treatment for presumptive TB patients in Uganda and sub-Saharan Africa. The aim of this study is therefore to leverage SMS reminders, phone call and MM incentives in improving linkage to care of presumptive TB patients.
This will be a five arm multi-center individual randomized controlled trial implemented in selected high-volume health facilities in Uganda among 1548 presumptive TB patients. The study population will be presumptive TB patients aged 18 years and above identified within the study facilities who do not complete TB diagnosis same day. Completion of TB diagnosis will refer to submitting a sample and obtaining results from the test. Our hypothesis is that using SMS reminders, phone call and Mobile Money incentives will result in increase in the proportion of presumptive TB patients that complete diagnosis and pre-treatment TB cases that initiate treatment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The major challenge in meeting the WHO's End TB Strategy- reducing TB deaths by 90% and incidence by 80% is the cascading patient loss-to-follow-up (LTFU) along the continuum of TB care. Patients can be lost to follow-up after being identified as presumptive TB cases and never get to test for TB (pre-diagnosis LTFU) or those who test and are confirmed to have TB, can also be lost and never start TB treatment (pre-treatment LTFU). A systematic review found high levels of pre-treatment LTFU-ranging from 4 to 38%, and was higher in sub-Saharan Africa (18%) compared to Asia (13%). Consequences of pre-diagnosis and pre-treatment LTFU are; untreated TB patients are infectious and can transmit TB to others and not starting TB treatment at all, causes high morbidity and mortality. Therefore, monitoring outcomes of presumptive TB patients is equally important as monitoring treatment outcomes. Short message service (SMS), phone calls and mobile money (MM) incentives have shown promise by improving health outcomes such as uptake of immunization, adherence to TB treatment and ART. However, there is limited knowledge their effect in increasing linkage to care and treatment for presumptive TB patients in Uganda and sub-Saharan Africa. The aim of this study is therefore to leverage SMS reminders, phone call and MM incentives in improving linkage to care of presumptive TB patients.
This will be a five arm multi-center individual randomized controlled trial implemented in selected high-volume health facilities in Uganda among 1548 presumptive TB patients. The study population will be presumptive TB patients aged 18 years and above identified within the study facilities who do not complete TB diagnosis same day. Completion of TB diagnosis will refer to submitting a sample and obtaining results from the test.
The study arms will include; i) Standard of care (SOC - control group) ii) SMS only iii) phone call only iv) SMS and MM incentive v) Phone call and MM incentive
Our hypothesis is that using SMS reminders, phone call and Mobile Money incentives will result in increase in the proportion of presumptive TB patients that complete diagnosis and pre-treatment TB cases that initiate treatment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Mukono, Uganda
- Mukono General Hospital
-
Wakiso, Uganda
- Entebbe Regional Referral Hospital
-
Wakiso, Uganda
- Wakiso Health Center IV
-
-
Kasana
-
Luwero, Kasana, Uganda
- Luwero General Hospital
-
-
Makindye
-
Kampala, Makindye, Uganda
- Kiruddu National referral Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Presumptive TB patient (cough, fever, night sweats, weight loss)
- Requested to have GeneXpert testing
- Aged between 18 and 65 years
- Current resident in the study districts
- Willing to sign informed consent
- Owning a mobile phone
- Able to read
Exclusion Criteria:
- Participant plans to move out of the study area in the next 3 months
- Participation in another related study such as SMS, phone call or mobile money incentive and others
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Standard of care (Control)
Patients in this arm will receive the routine TB care, according to the Uganda Ministry of Health guidelines, that is; i) Patient screened for TB ii) Patient identified as presumptive and registered in the presumptive TB register iii) Patient referred for TB testing iv) Patient expected to return and pick results on their own drive vi) Positive TB patients initiated on treatment.
|
|
|
Experimental: SMS only
In addition to standard of care, participants in this arm will receive three SMS reminders.
The first SMS will be sent on day one after enrollment into the study.
The second SMS will be sent once participant results are ready.
If two days after the second SMS the patient has not returned to complete TB diagnosis, a third SMS will be sent.
Messages will be automatically sent in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
|
Participants in this arm will receive three SMS reminders.
The first SMS will be sent on day one after enrollment into the study.
The second SMS will be sent once participant results are ready.
If two days after the second SMS the patient has not returned to complete TB diagnosis, a third SMS will be sent.
Messages will be automatically sent in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
|
|
Experimental: Phone call only
In addition to standard of care, participants in this arm will receive three phone call reminders to complete TB diagnosis.
The first phone call will be made on day one after enrollment into the study.
The second phone call will be made once participant results are ready.
If two days after the second phone call the patient has not returned to complete TB diagnosis, a third phone call will be made.
Phone calls will be made in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
|
Participants in this arm will receive three phone call reminders.
The first phone call will be made on day one after enrollment into the study.
The second phone call will be made once participant results are ready.
If two days after the second phone call the patient has not returned to complete TB diagnosis, a third phone call will be made.
Phone calls will be made in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
|
|
Experimental: SMS and mobile money incentives
In addition to standard of care, participants in this arm will receive three SMS reminders and a transport refund once they complete TB diagnosis. The first SMS will be sent on day one after enrollment into the study. The second SMS will be sent once participant results are ready. If two days after the second SMS the patient has not returned to complete TB diagnosis, a third SMS will be sent. Messages will be automatically sent in either English or Luganda, the commonly spoken local language in the study area. The preferred language of the participant will be determined at enrollment. Once participants in this study arm complete TB diagnosis by submitting a sputum sample and collecting back results, a money incentive worth 20,000/= (Twenty thousand shillings only) will be given as a transport refund sent via mobile money. |
Participants in this arm will receive three SMS reminders.
The first SMS will be sent on day one after enrollment into the study.
The second SMS will be sent once participant results are ready.
If two days after the second SMS the patient has not returned to complete TB diagnosis, a third SMS will be sent.
Messages will be automatically sent in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
Once participants in the study arms with mobile money complete TB diagnosis by submitting a sputum sample and collecting back results, a money incentive worth 20,000/= (Twenty thousand shillings only) will be given as a transport refund sent via mobile money.
|
|
Experimental: Phone call and mobile money incentives
In addition to standard of care, participants in this arm will receive three phone call reminders and a transport refund once they complete TB diagnosis. The first phone call will be made on day one after enrollment into the study. The second phone call will be made once participant results are ready. If two days after the second phone call the patient has not returned to complete TB diagnosis, a third phone call will be made. Phone calls will be made in either English or Luganda, the commonly spoken local language in the study area. The preferred language of the participant will be determined at enrollment. Once participants in this study arm complete TB diagnosis by submitting a sputum sample and collecting back results, a money incentive worth 20,000/= (Twenty thousand shillings only) will be given as a transport refund sent via mobile money. |
Participants in this arm will receive three phone call reminders.
The first phone call will be made on day one after enrollment into the study.
The second phone call will be made once participant results are ready.
If two days after the second phone call the patient has not returned to complete TB diagnosis, a third phone call will be made.
Phone calls will be made in either English or Luganda, the commonly spoken local language in the study area.
The preferred language of the participant will be determined at enrollment.
Once participants in the study arms with mobile money complete TB diagnosis by submitting a sputum sample and collecting back results, a money incentive worth 20,000/= (Twenty thousand shillings only) will be given as a transport refund sent via mobile money.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Completion of TB diagnosis
Time Frame: 30 days (from being identified as presumptive TB patient)
|
This will include completing TB diagnosis using laboratory investigations (GeneXpert) 30 days after being identified as presumptive.
This will also include the patient receiving results when ready.
|
30 days (from being identified as presumptive TB patient)
|
|
Median time to completing TB diagnosis
Time Frame: Up to 30 days. Determined as Time from when the patient is enrolled on the study to when they complete TB diagnosis
|
The time a participant took to complete diagnosis from when they were presumed for TB.
|
Up to 30 days. Determined as Time from when the patient is enrolled on the study to when they complete TB diagnosis
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Initiation of TB treatment
Time Frame: 30 days after being confirmed with TB
|
This will include initiating treatment within 30 days after being confirmed with TB
|
30 days after being confirmed with TB
|
|
Median time to initiating treatment
Time Frame: Up to 30 days. Determined as Time from when the patient is confirmed to have TB to when they initiate TB treatment
|
The time a participant took to initiate treatment once confirmed to have TB
|
Up to 30 days. Determined as Time from when the patient is confirmed to have TB to when they initiate TB treatment
|
|
Acceptability of the intervention
Time Frame: Through study completion, an average of two months
|
This will refer to how acceptable the short message service, phone call and mobile money incentives intervention is in terms of performance, effort, social norms, and facilitating conditions.
This will be a post intervention qualitative evaluation
|
Through study completion, an average of two months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Esther Buregyeya, PhD, Makerere University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MILEAGE4TB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.